We work where pathogens emerge. By working locally and collaborating globally, our network of data and people can react rapidly to fresh outbreaks and stay on top of existing incidents.
Our collaborations enable us to do cutting-edge work.
Our global relationships with governments, health agencies, academic institutions and private enterprise exist on nearly every continent and offer Metabiota unparalleled access to emerging events.
From epidemiological research to probabilistic modeling, we work with the academic sector to develop transformative solutions with real-world applications.
Metabiota products provide insurance, pharmaceutical and other commercial customers with highly granular intelligence on the latest infectious disease risks and trends.
We partner with governments worldwide to develop a new awareness of pathogenic impact surveillance, learn from their experiences and bolster our network of reference data.
We are constantly expanding our understanding of emerging infectious diseases.
From tracking viruses before they jump to humans to finding new ways to turn big data into meaningful insights — we are pushing the boundaries of predictive and prescriptive analytics for infectious disease threats.